CA2448757A1 - Accurate and efficient quantification of dna sensitivity by real-time pcr - Google Patents
Accurate and efficient quantification of dna sensitivity by real-time pcr Download PDFInfo
- Publication number
- CA2448757A1 CA2448757A1 CA002448757A CA2448757A CA2448757A1 CA 2448757 A1 CA2448757 A1 CA 2448757A1 CA 002448757 A CA002448757 A CA 002448757A CA 2448757 A CA2448757 A CA 2448757A CA 2448757 A1 CA2448757 A1 CA 2448757A1
- Authority
- CA
- Canada
- Prior art keywords
- dna
- modifying agent
- chromatin
- genome
- sensitivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 25
- 230000035945 sensitivity Effects 0.000 title claims abstract description 24
- 238000011002 quantification Methods 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 55
- 108010077544 Chromatin Proteins 0.000 claims abstract description 45
- 210000003483 chromatin Anatomy 0.000 claims abstract description 45
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 35
- 210000004027 cell Anatomy 0.000 claims abstract description 32
- 108020004414 DNA Proteins 0.000 claims description 130
- 108091093088 Amplicon Proteins 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 230000003321 amplification Effects 0.000 claims description 16
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 16
- 241000894007 species Species 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 9
- 101710163270 Nuclease Proteins 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 5
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 230000011987 methylation Effects 0.000 claims description 4
- 238000007069 methylation reaction Methods 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 230000030933 DNA methylation on cytosine Effects 0.000 claims description 3
- 108010042407 Endonucleases Proteins 0.000 claims description 3
- 102000004533 Endonucleases Human genes 0.000 claims description 3
- 101710183280 Topoisomerase Proteins 0.000 claims description 3
- 238000009825 accumulation Methods 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 108010013043 Acetylesterase Proteins 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 239000012829 chemotherapy agent Substances 0.000 claims description 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 2
- 229940014144 folate Drugs 0.000 claims description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 230000006195 histone acetylation Effects 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000012286 potassium permanganate Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000010008 shearing Methods 0.000 claims description 2
- 108010059724 Micrococcal Nuclease Proteins 0.000 claims 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 claims 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 claims 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 44
- 238000004458 analytical method Methods 0.000 abstract description 14
- 239000000835 fiber Substances 0.000 abstract description 4
- 238000011835 investigation Methods 0.000 abstract description 2
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000029087 digestion Effects 0.000 description 32
- 108090000623 proteins and genes Proteins 0.000 description 18
- 210000004940 nucleus Anatomy 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 108010047956 Nucleosomes Proteins 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 230000001605 fetal effect Effects 0.000 description 10
- 210000001623 nucleosome Anatomy 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000002105 Southern blotting Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000000925 erythroid effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108091023040 Transcription factor Proteins 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 5
- 108060003196 globin Proteins 0.000 description 5
- 238000011880 melting curve analysis Methods 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 241000699660 Mus musculus Species 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 238000011830 transgenic mouse model Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 230000008836 DNA modification Effects 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 3
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 3
- 102000003893 Histone acetyltransferases Human genes 0.000 description 3
- 108090000246 Histone acetyltransferases Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 210000000267 erythroid cell Anatomy 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 102000018146 globin Human genes 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000003007 single stranded DNA break Effects 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 238000003239 susceptibility assay Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- LZJPDRANSVSGOR-UHFFFAOYSA-N 1-(4-azidophenyl)-2-bromoethanone Chemical compound BrCC(=O)C1=CC=C(N=[N+]=[N-])C=C1 LZJPDRANSVSGOR-UHFFFAOYSA-N 0.000 description 1
- HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 1
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
- 108091029461 Constitutive heterochromatin Proteins 0.000 description 1
- 102000003915 DNA Topoisomerases Human genes 0.000 description 1
- 108090000323 DNA Topoisomerases Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102100036646 Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Human genes 0.000 description 1
- 108091005879 Hemoglobin subunit epsilon Proteins 0.000 description 1
- 108010034791 Heterochromatin Proteins 0.000 description 1
- 108090000353 Histone deacetylase Proteins 0.000 description 1
- 102100038720 Histone deacetylase 9 Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001076862 Homo sapiens C-Jun-amino-terminal kinase-interacting protein 4 Proteins 0.000 description 1
- 101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 description 1
- 101001083591 Homo sapiens Hemoglobin subunit epsilon Proteins 0.000 description 1
- 101001023770 Homo sapiens Transcription factor NF-E2 45 kDa subunit Proteins 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 1
- 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101000713102 Mus musculus C-C motif chemokine 1 Proteins 0.000 description 1
- 101000737276 Mus musculus Carbonyl reductase [NADPH] 2 Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 102100035412 Transcription factor NF-E2 45 kDa subunit Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 108091027569 Z-DNA Proteins 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 108091006090 chromatin-associated proteins Proteins 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- -1 dNTPs Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 210000004458 heterochromatin Anatomy 0.000 description 1
- 102000052921 human SPAG9 Human genes 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29489001P | 2001-05-30 | 2001-05-30 | |
| US60/294,890 | 2001-05-30 | ||
| PCT/US2002/016967 WO2002097135A1 (en) | 2001-05-30 | 2002-05-30 | Accurate and efficient quantification of dna sensitivity by real-time pcr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2448757A1 true CA2448757A1 (en) | 2002-12-05 |
Family
ID=23135383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002448757A Abandoned CA2448757A1 (en) | 2001-05-30 | 2002-05-30 | Accurate and efficient quantification of dna sensitivity by real-time pcr |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1402072A4 (enExample) |
| JP (1) | JP2005522981A (enExample) |
| CA (1) | CA2448757A1 (enExample) |
| WO (1) | WO2002097135A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005058931A2 (en) * | 2003-12-15 | 2005-06-30 | Regulome Corporation | Methods and algorithms for identifying genomic regulatory sites |
| SG171916A1 (en) * | 2008-12-02 | 2011-07-28 | Bio Rad Laboratories | Chromatin structure detection |
| WO2012034013A2 (en) | 2010-09-10 | 2012-03-15 | Bio-Rad Laboratories, Inc. | Detection of rna-interacting regions in dna |
| EP2441520A1 (en) | 2010-10-12 | 2012-04-18 | Eppendorf AG | Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay |
| US20120208193A1 (en) | 2011-02-15 | 2012-08-16 | Bio-Rad Laboratories, Inc. | Detecting methylation in a subpopulation of genomic dna |
| CN107400711A (zh) | 2011-08-03 | 2017-11-28 | 伯乐实验室公司 | 使用透化处理的细胞过滤小核酸 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5180666A (en) * | 1991-06-27 | 1993-01-19 | Wayne State University | Method and cell line for testing mutagenicity of a chemical |
| US6210878B1 (en) * | 1997-08-08 | 2001-04-03 | The Regents Of The University Of California | Array-based detection of genetic alterations associated with disease |
| US6180349B1 (en) * | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
| AU6201000A (en) * | 1999-09-01 | 2001-03-26 | Bristol-Myers Squibb Company | In vitro transcription systems and uses |
-
2002
- 2002-05-30 EP EP02752010A patent/EP1402072A4/en not_active Withdrawn
- 2002-05-30 WO PCT/US2002/016967 patent/WO2002097135A1/en not_active Ceased
- 2002-05-30 JP JP2003500299A patent/JP2005522981A/ja active Pending
- 2002-05-30 CA CA002448757A patent/CA2448757A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002097135A9 (en) | 2003-03-20 |
| WO2002097135A1 (en) | 2002-12-05 |
| JP2005522981A (ja) | 2005-08-04 |
| EP1402072A4 (en) | 2005-11-16 |
| EP1402072A1 (en) | 2004-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McArthur et al. | Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse β-globin LCR | |
| JP4917891B2 (ja) | 差次的酵素的断片化の方法 | |
| US6114115A (en) | Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification | |
| EP2675913B1 (en) | Detecting methylation in a subpopulation of genomic dna | |
| Eads et al. | Combined bisulfite restriction analysis (COBRA) | |
| JP6273198B2 (ja) | 定量的ｐｃｒによる、ホルマリン固定パラフィン包埋（ｆｆｐｅ）試料におけるテロメア長測定 | |
| US6586181B1 (en) | Method for detecting allelic imbalance | |
| KR102648647B1 (ko) | 짧은 호모폴리머릭 반복서열의 개선된 검출법 | |
| US5919623A (en) | Nucleic acid mutation assays | |
| JP7712208B2 (ja) | 標的核酸の検出方法 | |
| Scholl et al. | Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia | |
| AU2005212393B2 (en) | CpG-amplicon and array protocol | |
| JP2003518951A (ja) | 多型核酸配列の同時増幅およびリアルタイム検出のための方法 | |
| WO1995029258A1 (en) | Nucleic acid mutation assays | |
| Bonanno et al. | MS-FLAG, a novel real-time signal generation method for methylation-specific PCR | |
| CA2448757A1 (en) | Accurate and efficient quantification of dna sensitivity by real-time pcr | |
| Jenkins et al. | The restriction site mutation assay: a review of the methodology development and the current status of the technique | |
| JP2020182457A (ja) | 核酸増幅の特異的抑制方法 | |
| Aldape et al. | Real‐time quantitative polymerase chain reaction: a potential tool for genetic analysis in neuropathology | |
| US6762018B1 (en) | Analysis of nucleotide polymorphisms at a site | |
| Kang et al. | Role of the promoter in maintaining transcriptionally active chromatin structure and DNA methylation patterns in vivo | |
| AU2002344224A1 (en) | Accurate and efficient quantification of DNA sensitivity by real-time PCR | |
| JP4650420B2 (ja) | 塩基判定方法及び塩基判定用キット | |
| CN119193821A (zh) | 用于检测食管癌的标记物及检测方法 | |
| Christian | A cytogenetic footprint for mammary carcinomas induced by PhIP in rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20080530 |